Anebulo Pharmaceuticals Inc (ANEB)
1.84
-0.04
(-2.13%)
USD |
NASDAQ |
Nov 01, 16:00
Anebulo Pharmaceuticals Price to Book Value: 12.52 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 12.52 |
| October 31, 2024 | 12.79 |
| October 30, 2024 | 12.58 |
| October 29, 2024 | 12.89 |
| October 28, 2024 | 12.45 |
| October 25, 2024 | 12.45 |
| October 24, 2024 | 12.92 |
| October 23, 2024 | 12.86 |
| October 22, 2024 | 12.52 |
| October 21, 2024 | 12.65 |
| October 18, 2024 | 13.34 |
| October 17, 2024 | 12.45 |
| October 16, 2024 | 12.86 |
| October 15, 2024 | 12.92 |
| October 14, 2024 | 12.45 |
| October 11, 2024 | 12.79 |
| October 10, 2024 | 12.72 |
| October 09, 2024 | 13.26 |
| October 08, 2024 | 12.86 |
| October 07, 2024 | 13.03 |
| October 04, 2024 | 13.26 |
| October 03, 2024 | 12.99 |
| October 02, 2024 | 13.47 |
| October 01, 2024 | 13.50 |
| September 30, 2024 | 13.13 |
| Date | Value |
|---|---|
| September 27, 2024 | 13.94 |
| September 26, 2024 | 13.33 |
| September 25, 2024 | 12.58 |
| September 24, 2024 | 14.22 |
| September 23, 2024 | 15.10 |
| September 20, 2024 | 20.95 |
| September 19, 2024 | 14.15 |
| September 18, 2024 | 13.60 |
| September 17, 2024 | 15.44 |
| September 16, 2024 | 14.22 |
| September 13, 2024 | 14.15 |
| September 12, 2024 | 14.22 |
| September 11, 2024 | 12.04 |
| September 10, 2024 | 13.13 |
| September 09, 2024 | 12.99 |
| September 06, 2024 | 12.24 |
| September 05, 2024 | 12.24 |
| September 04, 2024 | 12.79 |
| September 03, 2024 | 12.31 |
| August 30, 2024 | 13.06 |
| August 29, 2024 | 12.42 |
| August 28, 2024 | 12.42 |
| August 27, 2024 | 13.81 |
| August 26, 2024 | 13.23 |
| August 23, 2024 | 14.22 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.400
Minimum
Oct 21 2022
20.95
Maximum
Sep 20 2024
7.860
Average
7.463
Median
Price to Book Value Benchmarks
| Revance Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.082 |
| Theriva Biologics Inc | 0.0772 |
Price to Book Value Related Metrics
| Price | 1.84 |
| Earnings Yield | -17.39% |
| Market Cap | 47.72M |